<aside>
This dashboard summarises the current evidence behind IMPALA’s impact. It maps each key claim to the evidence that supports it, including clinical outcomes, implementation findings, usability evidence, cost-effectiveness analysis, and remaining evidence gaps. It is designed to support transparent use of evidence in proposals, partner conversations, funder due diligence, and internal learning.
For a shorter summary of our evidence, please have a look at IMPALA’s impact at a glance
Each row is one claim from IMPALA's Theory of Change, and the claims build on each other. C1–C3 cover whether the technology works and can be sustained and scaled; C4–C7 how health workers and caregivers use it; C8–C10 how it changes care; and C11–C13 the effects on health outcomes and costs.
For each claim, the table shows a short summary of the quantitative and qualitative evidence, the evidence grade and the main conclusion. Click a Claim ID to open the full synthesis in a side window, with its sources linked and the questions that remain open. Claims link to each other, so you can follow the chain from technical reliability to outcomes.
For any questions or corrections, please email [email protected]
</aside>
| Evidence grade | Definition |
|---|---|
| Well established | Consistent findings across multiple independent studies or sources |
| Developing evidence | Supported by at least one well-designed study, with consistent findings |
| Emerging / limited evidence | Based on limited, preliminary, or methodologically constrained evidence |